Stock screenerAll disclosures →
EDGAR →
EYPT
Conviction 31IndustrialsScan · Mon, Aug 10, 2026EYPT$13.06-5.98%
ResistanceSupportVol 14Insider sellVol MA14 2.04M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price13.06
Change-5.98%
Gap+2.12%
Rel volume3.46×
Avg volume1.83M
Avg $ vol23.23M
SMA 2012.72
SMA 5013.09
SMA 20014.11
Price vs 50-0.25%
Price vs 200-7.47%
MA stackbearish
50/200 cross—
Supertrenddown · 14.53
RSI (14)51
MACD hist0.11
MACD crossbull · 1d
Stoch %K / %D55 / 68
ADX (14)12
+DI / −DI21 / 13
RSI divergence—
MACD divergence—
ATR %+7.34%
ADR %6.96%
52w high18.85
52w low10.23
From 52w high-30.72%
Above 52w low+27.66%
New 52w highNo
SqueezeOn · 1d
Bollinger width19.46%
%B0.64
Donchian pos50.00%
Donchian high14.58
Donchian low11.54
AVWAP (52w high)14.36
vs AVWAP high-9.05%
AVWAP (52w low)14.22
vs AVWAP low-8.15%
OBV trendDown
Chaikin MF (20)-0.23
Today vs 20d3.46×
Avg vol (14d)2.04M
Avg vol (20d)1.83M
Avg $ vol (20d)23.23M
Market cap1.13B
RS 3m (vs SPY)-2.12%
RS 6m (vs SPY)-5.00%
RS line new highNo
Trend template0/8
Technical rank28.6
1 week+5.15%
1 month-11.28%
3 months-4.39%
6 months-1.80%
1 year+29.69%
YTD-25.29%
P/E-4.85
P/B6.77
P/S35.89
P/FCF-4.63
EPS-3.17
Div yield—
ROE-139.39%
ROA-101.65%
Debt/Eq0.00
Current4.50
EV/EBITDA-4.21
Gross margin—
Net margin-739.42%
Rev growth-27.50%
EPS growth-77.25%
Price target40.75
Target upside212.02%
Analyst ratingBuy
Institutional111.44%
Ent. value1.02B
Revenue507K
Net income-94.47M
Gross profit—
Free cash flow-243.39M
IndustryLABORATORY ANALYTICAL INSTRUMENTS
ExchangeNasdaq
Shares out83.84M
Employees214
ListedThu, Jan 27, 2005
Free float81.36M
Float %98.3%
Short interest16.43M
Days to cover10.3d
Short volume59.1%
Squeeze score93 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$1.09 vs −$0.92
Last surprise-18.5% miss
Setup gradeD
Conviction31 / 100
Pattern quality—
Tech rank28.6 / 100
Group rank68 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance15.46
Support11.55
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in EYPT
No recent disclosed trades by Congress in EYPT. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in EYPT · 2 buys · 4 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Elston George Chief Financial Officer · Common Stock · 2026-05-25 | Tax | 3.63K | $47K | 2026-05-25 | 2026-05-27 |
Elston George Chief Financial Officer · Restricted Stock Units · 2026-05-25 | Exercise | 7.5K | $0 | 2026-05-25 | 2026-05-27 |
Elston George Chief Financial Officer · Common Stock · 2026-05-25 | Other | — | — | 2026-05-25 | 2026-05-27 |
Elston George Chief Financial Officer · Common Stock · 2026-05-25 | Exercise | 7.5K | $0 | 2026-05-25 | 2026-05-27 |
Ribeiro Ramiro Chief Medical Officer · Common Stock · 2026-04-17 | Sell | 2.44K | $37K | 2026-04-17 | 2026-04-20 |
Ribeiro Ramiro Chief Medical Officer · Common Stock · 2026-04-17 | Exercise | 2.44K | $20K | 2026-04-17 | 2026-04-20 |
Ribeiro Ramiro Chief Medical Officer · Stock Option (Right to Buy) · 2026-04-17 | Exercise | 2.44K | $0 | 2026-04-17 | 2026-04-20 |
SEC filings
EDGAR filings in EYPT · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.